Molecular profiles of thyroid cancer subtypes: Classification based on features of tissue revealed by mass spectrometry imaging.

Determination of the specific type of thyroid cancer is crucial for the prognosis and selection of treatment of this malignancy. However, in some cases appropriate classification is not possible based on histopathological features only, and it might be supported by molecular biomarkers. Here we aimed to characterize molecular profiles of different thyroid malignancies using mass spectrometry imaging (MSI) which enables the direct annotation of molecular features with morphological pictures of an analyzed tissue. Fifteen formalin-fixed paraffin-embedded tissue specimens corresponding to five major types of thyroid cancer were analyzed by MALDI-MSI after in-situ trypsin digestion, and the possibility of classification based on the results of unsupervised segmentation of MALDI images was tested. Novel method of semi-supervised detection of the cancer region of interest (ROI) was implemented. We found strong separation of medullary cancer from malignancies derived from thyroid epithelium, and separation of anaplastic cancer from differentiated cancers. Reliable classification of medullary and anaplastic cancers using an approach based on automated detection of cancer ROI was validated with independent samples. Moreover, extraction of spectra from tumor areas allowed the detection of molecular components that differentiated follicular cancer and two variants of papillary cancer (classical and follicular). We concluded that MALDI-MSI approach is a promising strategy in the search for biomarkers supporting classification of thyroid malignant tumors. This article is part of a Special Issue entitled: MALDI Imaging, edited by Dr. Corinna Henkel and Prof. Peter Hoffmann.

[1]  Fulvio Magni,et al.  Proteomics in thyroid cytopathology: Relevance of MALDI‐imaging in distinguishing malignant from benign lesions , 2016, Proteomics.

[2]  André M Deelder,et al.  De novo discovery of phenotypic intratumour heterogeneity using imaging mass spectrometry , 2015, The Journal of pathology.

[3]  Joanna Polanska,et al.  Detection of molecular signatures of oral squamous cell carcinoma and normal epithelium – application of a novel methodology for unsupervised segmentation of imaging mass spectrometry data , 2016, Proteomics.

[4]  Kristina Schwamborn,et al.  Molecular imaging by mass spectrometry — looking beyond classical histology , 2010, Nature Reviews Cancer.

[5]  David E. Misek,et al.  Molecular classification of papillary thyroid carcinoma: distinct BRAF, RAS, and RET/PTC mutation-specific gene expression profiles discovered by DNA microarray analysis , 2005, Oncogene.

[6]  Steven J. M. Jones,et al.  Integrated Genomic Characterization of Papillary Thyroid Carcinoma , 2014, Cell.

[7]  Richard M. Caprioli,et al.  Molecular Assessment of the Tumor Protein Microenvironment Using Imaging Mass Spectrometry , 2006 .

[8]  K. Shroyer,et al.  Quantitative and qualitative differences in protein expression between papillary thyroid carcinoma and normal thyroid tissue , 2006, Molecular carcinogenesis.

[9]  R. Paschke,et al.  Molecular fine-needle aspiration biopsy diagnosis of thyroid nodules by tumor specific mutations and gene expression patterns , 2010, Molecular and Cellular Endocrinology.

[10]  H. Shim,et al.  Molecular proteomics imaging of tumor interfaces by mass spectrometry. , 2010, Journal of proteome research.

[11]  F. Pagni,et al.  Proteomics for the diagnosis of thyroid lesions: preliminary report , 2015, Cytopathology : official journal of the British Society for Clinical Cytology.

[12]  Steven J. M. Jones,et al.  Biomarker panel diagnosis of thyroid cancer: a critical review , 2008, Expert review of anticancer therapy.

[13]  Heinz Höfler,et al.  MALDI imaging mass spectrometry in cancer research: combining proteomic profiling and histological evaluation. , 2013, Clinical biochemistry.

[14]  Krzysztof Fujarewicz,et al.  A multi-gene approach to differentiate papillary thyroid carcinoma from benign lesions: gene selection using support vector machines with bootstrapping , 2007, Endocrine-related cancer.

[15]  M. Prasad,et al.  Follicular Variant of Papillary Thyroid Carcinoma: Accuracy of FNA Diagnosis and Implications for Patient Management , 2014, Endocrine Pathology.

[16]  Joanna Polanska,et al.  Signal Partitioning Algorithm for Highly Efficient Gaussian Mixture Modeling in Mass Spectrometry , 2015, PloS one.

[17]  R. Lloyd,et al.  Calcitonin, carcinoembryonic antigen and neuron‐specific enolase in medullary thyroid carcinoma. An immunohistochemical study , 1983, Cancer.

[18]  K. Polański,et al.  Detection of metabolites discriminating subtypes of thyroid cancer: Molecular profiling of FFPE samples using the GC/MS approach , 2015, Molecular and Cellular Endocrinology.

[19]  C. Badiu,et al.  Endoplasmic Reticulum Chaperones Are Potential Active Factors in Thyroid Tumorigenesis. , 2016, Journal of proteome research.

[20]  F. Magni,et al.  Proteome analysis in thyroid pathology , 2015, Expert review of proteomics.

[21]  O. Sheils,et al.  A molecular expression signature distinguishing follicular lesions in thyroid carcinoma using preamplification RT-PCR in archival samples , 2007, Modern Pathology.

[22]  W. Kim,et al.  Imaging Mass Spectrometry in Papillary Thyroid Carcinoma for the Identification and Validation of Biomarker Proteins , 2014, Journal of Korean medical science.

[23]  Richard M Caprioli,et al.  Tissue Profiling by Mass Spectrometry , 2005, Molecular & Cellular Proteomics.

[24]  Richard M Caprioli,et al.  MALDI imaging mass spectrometry of human tissue: method challenges and clinical perspectives. , 2011, Trends in biotechnology.

[25]  Michelle L. Reyzer,et al.  MALDI imaging mass spectrometry: molecular snapshots of biochemical systems , 2007, Nature Methods.

[26]  A. Walch,et al.  MALDI Imaging mass spectrometry: current frontiers and perspectives in pathology research and practice , 2015, Laboratory Investigation.

[27]  M. Zeiger,et al.  The Impact of Molecular Testing on the Surgical Management of Patients with Thyroid Nodules , 2014, Annals of Surgical Oncology.

[28]  M. Schlumberger,et al.  Papillary and follicular thyroid carcinoma. , 1998, The New England journal of medicine.

[29]  Fulvio Magni,et al.  An Alternative Approach in Endocrine Pathology Research: MALDI-IMS in Papillary Thyroid Carcinoma , 2013, Endocrine Pathology.

[30]  E. Hernández-Lemus,et al.  Genome-wide expression analysis suggests a crucial role of dysregulation of matrix metalloproteinases pathway in undifferentiated thyroid carcinoma , 2015, BMC Genomics.

[31]  M. Schlumberger.  Cancer papillaire et folliculaire de la thyroïde , 2007 .

[32]  A. Jemal,et al.  Cancer statistics, 2015 , 2015, CA: a cancer journal for clinicians.

[33]  Richard M Caprioli,et al.  Molecular analysis of tumor margins by MALDI mass spectrometry in renal carcinoma. , 2010, Journal of proteome research.

[34]  K. Krause,et al.  Proteomics in thyroid tumor research. , 2009, The Journal of clinical endocrinology and metabolism.

[35]  R. DeLellis.  Pathology and genetics of tumours of endocrine organs , 2004 .

[36]  C. Larsson,et al.  Proteomic profiling of follicular and papillary thyroid tumors , 2011, European journal of endocrinology.

[37]  T. Igarashi,et al.  Proteomic Profiling of Thyroid Papillary Carcinoma , 2012, Journal of thyroid research.

[38]  G. Sakorafas.  Thyroid nodules; interpretation and importance of fine-needle aspiration (FNA) for the clinician - practical considerations. , 2010, Surgical oncology.

[39]  W. Faquin.  The thyroid gland: recurring problems in histologic and cytologic evaluation. , 2009, Archives of pathology & laboratory medicine.

[40]  Horst Zitzelsberger,et al.  Tumor classification of six common cancer types based on proteomic profiling by MALDI imaging. , 2012, Journal of proteome research.

[41]  A. Miyauchi,et al.  Introducing the reporting system for thyroid fine-needle aspiration cytology according to the new guidelines of the Japan Thyroid Association. , 2014, Endocrine journal.

[42]  G. Salabé.  Pathogenesis of thyroid nodules: histological classification? , 2001, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[43]  Emrys A. Jones,et al.  Imaging mass spectrometry-based molecular histology differentiates microscopically identical and heterogeneous tumors. , 2013, Journal of proteome research.

[44]  R. Paschke,et al.  Perspectives and limitations of microarray-based gene expression profiling of thyroid tumors. , 2007, Endocrine reviews.

[45]  B. Haugen,et al.  Discovery and validation of protein abundance differences between follicular thyroid neoplasms. , 2008, Cancer research.

[46]  Monika Pietrowska,et al.  Application of Metabolomics in Thyroid Cancer Research , 2015, International journal of endocrinology.

[47]  Chr. Hedinger,et al.  Histological Typing of Thyroid Tumours , 1988, World Health Organization.

[48]  M. Cakir,et al.  Medullary thyroid carcinoma, follicular variant , 2002, Endocrine pathology.

[49]  Liam A McDonnell,et al.  Imaging mass spectrometry. , 2007, Mass spectrometry reviews.

[50]  Orlando Guntinas-Lichius,et al.  MALDI-imaging segmentation is a powerful tool for spatial functional proteomic analysis of human larynx carcinoma , 2012, Journal of Cancer Research and Clinical Oncology.

[51]  Y. Oertel,et al.  Classification of Thyroid Malignancies , 2000 .

[52]  K. Schwamborn,et al.  Proteomic tissue profiling for the improvement of grading of noninvasive papillary urothelial neoplasia. , 2012, Clinical biochemistry.

[53]  K. Sewell.  CALCITONIN. , 1965, Reactions Weekly.

[54]  D. Larsimont,et al.  Intratumor heterogeneity and clonal evolution in an aggressive papillary thyroid cancer and matched metastases. , 2015, Endocrine-related cancer.

[55]  M. Mann,et al.  Proteomic workflow for analysis of archival formalin‐fixed and paraffin‐embedded clinical samples to a depth of 10 000 proteins , 2013, Proteomics. Clinical applications.

[56]  Krzysztof Fujarewicz,et al.  Gene expression profile of papillary thyroid cancer: sources of variability and diagnostic implications. , 2005, Cancer research.

[57]  Joanna Polanska,et al.  Adaptive filtering of microarray gene expression data based on Gaussian mixture decomposition , 2013, BMC Bioinformatics.